ACCC clears Allianz Partners to acquire nib’s travel insurance portfolio
Australian regulator approves proposed deal, paving the way for Allianz Partners to expand its travel insurance presence across Australia and New Zealand
The Australian Competition and Consumer Commission (ACCC) has cleared Allianz Partners’ proposed acquisition of a significant portion of nib Group’s Australian and New Zealand travel insurance portfolio.
The clearance, granted under Australia’s new mandatory merger control regime introduced in January 2026, allows the transaction to proceed following regulatory review. The ACCC has yet to publish its detailed competition assessment but approved the deal without conditions.
Under the proposed transaction, Allianz Partners will acquire the Travel Insurance Direct (TID) brand, a substantial portfolio of nib’s travel insurance intermediary relationships in Australia, and enter into a 20-year white-label distribution agreement with nib covering both Australia and New Zealand.
The agreement is valued at up to A$50 million (approx. US$34.83 million), comprising approximately A$30 million payable on completion and a further A$20 million subject to agreed performance conditions during the first 12 months. Nib will also continue to receive distribution commissions under the long-term arrangement.
For Allianz Partners, the acquisition will significantly expand its travel insurance distribution network and customer reach in Australasia. Operating through AWP Australia Pty Ltd as Allianz Global Assistance, the company provides travel insurance and assistance services on behalf of Allianz Australia Insurance Limited.
The clearance also represents a major step in nib’s strategic withdrawal from travel insurance underwriting. The company announced plans to divest its travel insurance business in 2025 as part of a broader strategy to simplify its portfolio and focus capital on its core health insurance and healthcare operations.
Earlier this year, nib agreed to sell its World Nomads business to International Medical Group, a wholly owned subsidiary of SiriusPoint, for A$67.5 million. Together with the proposed Allianz Partners transaction, the divestments represent up to A$117.5 million in disclosed proceeds from nib’s planned exit from the travel insurance underwriting market.
Chris McHugh, Chief Executive Officer of Allianz Partners Australia, said: “Receiving regulatory approval is an important milestone that brings us closer to welcoming nib’s travel insurance customers and partners into the Allianz Partners family. We look forward to delivering world-class insurance and assistance products to even more Australian and New Zealand travellers.”
The ACCC said it had determined that the proposed acquisition was unlikely to have the effect of substantially lessening competition in any market, allowing the transaction to proceed without conditions.